These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33479841)

  • 1. Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.
    Cho S; Lee H; Seo J
    Mol Neurobiol; 2021 Jun; 58(6):2608-2619. PubMed ID: 33479841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism: A link between traumatic brain injury and Alzheimer's disease.
    Xu XJ; Yang MS; Zhang B; Niu F; Dong JQ; Liu BY
    Chin J Traumatol; 2021 Feb; 24(1):5-10. PubMed ID: 33358332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA
    Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunctional Glucose Metabolism in Alzheimer's Disease Onset and Potential Pharmacological Interventions.
    Kumar V; Kim SH; Bishayee K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
    Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
    Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer's disease.
    Miller JE; Shivakumar MK; Lee Y; Han S; Horgousluoglu E; Risacher SL; Saykin AJ; Nho K; Kim D;
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):76. PubMed ID: 30255815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol in Alzheimer's disease.
    Shobab LA; Hsiung GY; Feldman HH
    Lancet Neurol; 2005 Dec; 4(12):841-52. PubMed ID: 16297842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation and neuronal energy status: Implications for Alzheimer's disease.
    Pinho TS; Verde DM; Correia SC; Cardoso SM; Moreira PI
    Ageing Res Rev; 2018 Sep; 46():32-41. PubMed ID: 29787816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease.
    Deng S; Yi P; Xu M; Yi Q; Feng J
    Chin Med J (Engl); 2023 Mar; 136(6):666-675. PubMed ID: 35830275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies for Alzheimer's disease: a metabolic perspective.
    Domingues R; Pereira C; Cruz MT; Silva A
    Mol Genet Metab; 2021 Mar; 132(3):162-172. PubMed ID: 33549409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and Rare Genetic Variants Associated With Alzheimer's Disease.
    Marei HE; Althani A; Suhonen J; El Zowalaty ME; Albanna MA; Cenciarelli C; Wang T; Caceci T
    J Cell Physiol; 2016 Jul; 231(7):1432-7. PubMed ID: 26496533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics: New Light on Alzheimer's Disease Research.
    Jung YJ; Kim YH; Bhalla M; Lee SB; Seo J
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer's Disease.
    Szablewski L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.